Prognostic tools at hospital arrival in acute myocardial infarction: copeptin and hepatocyte growth factor.
Maria Consuelo PintadoLara MacedaMaría TrascasaIgnacio ArribasRaúl De PabloPublished in: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology (2022)
In patients with acute myocardial infarction measurement of copeptin at hospital arrival could be a useful tool to assess the prognosis of these patients, since their elevation is associated with a higher hospital mortality and higher 1-year follow-up mortality. We have not found this association in the case of hepatocyte growth factor measurement.
Keyphrases
- growth factor
- acute myocardial infarction
- healthcare
- end stage renal disease
- acute care
- percutaneous coronary intervention
- cardiovascular events
- left ventricular
- ejection fraction
- chronic kidney disease
- adverse drug
- newly diagnosed
- liver injury
- peritoneal dialysis
- risk factors
- emergency department
- cardiovascular disease
- acute coronary syndrome
- patient reported outcomes
- drug induced